Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-2 study): a plain language summary.
Journal: Immunotherapy
Published: May 08, 2023
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial.
Journal: Journal of the American Academy of Dermatology
Published: June 22, 2022
Showing 1-2 of 2
Last Updated: 09/26/2026